Kjell Öberg

Menin represses JunD-activated transcription by a histone deacetylase-dependent mechanism.

M. Berg, B. Skogseid, M. Berg, 1999, Biochimica et biophysica acta.

Experience with multiple endocrine neoplasia type 1 screening

B. Skogseid, K. Öberg, Kjell Öberg, 1995, Journal of internal medicine.

A standardized meal stimulation test of the endocrine pancreas for early detection of pancreatic endocrine tumors in multiple endocrine neoplasia type 1 syndrome: five years experience.

E. Wilander, B. Skogseid, L. Wide, 1987, The Journal of clinical endocrinology and metabolism.

Medical treatment and long‐term survival in a prospective study of 84 patients with endocrine pancreatic tumors

E. Wilander, B. Skogseid, K. Öberg, 1990, Cancer.

Plasma chromogranin A in patients with multiple endocrine neoplasia type 1.

B. Skogseid, M. Stridsberg, D. Granberg, 1999, The Journal of clinical endocrinology and metabolism.

Clinical symptoms, hormone profiles, treatment, and prognosis in patients with gastric carcinoids

E. Wilander, B. Skogseid, M. Stridsberg, 1998, Gut.

hCG and hCG subunits as tumour markers in patients with endocrine pancreatic tumours and carcinoids.

L. Wide, K. Oberg, Kjell Öberg, 1981, Acta endocrinologica.

Genetic and clinical characteristics of multiple endocrine neoplasia type 1.

C. Larsson, B. Skogseid, K. Oberg, 1991, Acta oncologica.

Unusual complication of a pancreatic neuroendocrine tumor presenting with malignant hypercalcemia.

G. Kaltsas, L. Grimelius, A. Tsolakis, 2012, The Journal of clinical endocrinology and metabolism.